{"brief_title": "Nefazodone in the Treatment of Cocaine Dependence and Depression - 4", "brief_summary": "The purpose of this study is the use of Nefazodone in the treatment of cocaine dependence and depression comorbidity.", "detailed_description": "The objective of this study is to determine the safety and efficacy of nefazodone (Serzone ) in depressed cocaine dependent subjects. This is a hypothesis-testing study which will explore whether cocaine usage will be reduced in the nefazodone treatment group compared to a placebo control group.", "condition": "Substance-Related Disorders", "intervention_type": "Behavioral", "intervention_name": "Psychosocial Treatment", "arm_group_label": "Matched Placebo Tablet", "other_name": "or Individual Dug Counseling", "description": "All subjects attended a weekly 1-hour therapy session during the 8 week treatment period.", "criteria": "Inclusion Criteria: DSM-IV diagnosis of cocaine dependence, Depression score of 12 or above and history of depression. Males and non-pregnant, non-nursing females 21-55 years of age. Exclusion Criteria: Axis I diagnosis other than substance use disorder, major depression, anxiety of dysthymic disorder. Physiological dependence on alcohol. Significant medical or neurological history. Abnormal UA, CBC or Chem 23 (LFT's may be up to 3 times normal). Enrollment in an opiate-substitution treatment program within 45 days of enrollment in the present study.", "gender": "All", "minimum_age": "21 Years", "maximum_age": "55 Years", "healthy_volunteers": "No", "id": "NCT00015210.xml"}